Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Statistics

Total Valuation

TPEX:3205 has a market cap or net worth of TWD 3.46 billion. The enterprise value is 2.66 billion.

Market Cap	3.46B
Enterprise Value	2.66B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:3205 has 67.55 million shares outstanding. The number of shares has increased by 11.88% in one year.

Current Share Class	67.55M
Shares Outstanding	67.55M
Shares Change (YoY)	+11.88%
Shares Change (QoQ)	+46.54%
Owned by Insiders (%)	35.66%
Owned by Institutions (%)	n/a
Float	37.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.75
PB Ratio	3.27
P/TBV Ratio	3.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-48.97
EV / Sales	5.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-63.59

Financial Position

The company has a current ratio of 10.89, with a Debt / Equity ratio of 0.01.

Current Ratio	10.89
Quick Ratio	10.47
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	-371.77

Financial Efficiency

Return on equity (ROE) is -6.83% and return on invested capital (ROIC) is -4.53%.

Return on Equity (ROE)	-6.83%
Return on Assets (ROA)	-4.07%
Return on Invested Capital (ROIC)	-4.53%
Return on Capital Employed (ROCE)	-5.45%
Revenue Per Employee	3.98M
Profits Per Employee	-484,277
Employee Count	112
Asset Turnover	0.50
Inventory Turnover	14.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.27% in the last 52 weeks. The beta is 0.78, so TPEX:3205's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	+37.27%
50-Day Moving Average	50.48
200-Day Moving Average	38.34
Relative Strength Index (RSI)	47.65
Average Volume (20 Days)	662,598

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:3205 had revenue of TWD 446.03 million and -54.24 million in losses. Loss per share was -1.49.

Revenue	446.03M
Gross Profit	79.49M
Operating Income	-58.00M
Pretax Income	-53.95M
Net Income	-54.24M
EBITDA	-53.94M
EBIT	-58.00M
Loss Per Share	-1.49

Balance Sheet

The company has 810.98 million in cash and 5.39 million in debt, giving a net cash position of 805.59 million or 11.93 per share.

Cash & Cash Equivalents	810.98M
Total Debt	5.39M
Net Cash	805.59M
Net Cash Per Share	11.93
Equity (Book Value)	1.06B
Book Value Per Share	15.62
Working Capital	803.06M

Cash Flow

In the last 12 months, operating cash flow was -39.23 million and capital expenditures -2.53 million, giving a free cash flow of -41.76 million.

Operating Cash Flow	-39.23M
Capital Expenditures	-2.53M
Free Cash Flow	-41.76M
FCF Per Share	-0.62

Margins

Gross margin is 17.82%, with operating and profit margins of -13.00% and -12.16%.

Gross Margin	17.82%
Operating Margin	-13.00%
Pretax Margin	-12.10%
Profit Margin	-12.16%
EBITDA Margin	-12.09%
EBIT Margin	-13.00%
FCF Margin	n/a

Dividends & Yields

TPEX:3205 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.88%
Shareholder Yield	n/a
Earnings Yield	-1.57%
FCF Yield	-1.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 17, 2016. It was a forward split with a ratio of 1.048659339.

Last Split Date	Aug 17, 2016
Split Type	Forward
Split Ratio	1.048659339

Scores

TPEX:3205 has an Altman Z-Score of 9.09 and a Piotroski F-Score of 3.

Altman Z-Score	9.09
Piotroski F-Score	3